Examples of 'dabrafenib' in a sentence
Meaning of "dabrafenib"
A drug used in the treatment of certain types of cancer, typically administered orally
Show more definitions
- A drug for the treatment of cancers associated with a mutated version of the gene BRAF.
How to use "dabrafenib" in a sentence
Basic
Advanced
dabrafenib
Two such compounds are dabrafenib and vemurafenib.
Men taking trametinib in combination with dabrafenib.
Carcinogenicity studies with dabrafenib have not been conducted.
There is no specific treatment for an overdose of dabrafenib.
The dabrafenib capsules are to be swallowed whole with water.
Tafinlar contains the active substance dabrafenib.
Refer to the dabrafenib SmPC for further information.
Only when used in combination with dabrafenib.
Dabrafenib and trametinib combination therapy.
It is not known whether dabrafenib is excreted in human milk.
Check your skin regularly whilst taking dabrafenib.
Effects of dabrafenib on substance transport systems.
Please refer to the dabrafenib SmPC.
Effect of dabrafenib on other medicinal products.
Effects on spermatogenesis have been observed in animals given dabrafenib.
See also
Effects of dabrafenib on other medicinal products.
Used as monotherapy or in combination with dabrafenib.
Please see the dabrafenib SmPC.
Dabrafenib in combination with trametinib.
Chemotherapy can commence with dabrafenib.
Trametinib in combination with dabrafenib in patients with brain metastases.
Dabrafenib was taken twice daily.
Pancreatitis has been reported with dabrafenib in combination with trametinib.
Tafinlar is a medicine that contains the active substance dabrafenib.
Male fertility studies with dabrafenib have not been conducted.
It is used in combination with dabrafenib.
Effects of dabrafenib on other substances.
The active substance is dabrafenib.
Recommended dabrafenib dose modifications.
No clinical study has been conducted to evaluate the effect of pH on dabrafenib pharmacokinetics.
Pancreatitis has been reported in dabrafenib monotherapy and in combination with trametinib.
No studies have been conducted to investigate the pharmacokinetics of dabrafenib in paediatric patients.
Concomitant administration of dabrafenib with warfarin results in decreased warfarin exposure.
Effect of food on dabrafenib.
No dose modification of dabrafenib is required when taken in combination with trametinib.
Combination with dabrafenib.
Concomitant administration of dabrafenib with digoxin may result in decreased digoxin exposure.
New primary melanoma was reported in patients receiving trametinib in combination with dabrafenib.
There are no data from the use of dabrafenib in pregnant women.
No dose modification of dabrafenib is required when trametinib is taken in combination with dabrafenib.
Rhabdomyolysis has been reported in patients taking trametinib alone or in combination with dabrafenib.
Renal failure has been reported with dabrafenib in combination with trametinib.
Reversible haematological effects have been observed in dogs and rats given dabrafenib.
There are no data in humans for dabrafenib as monotherapy or in combination with trametinib.
There are insufficient data to evaluate the potential effect of race on dabrafenib pharmacokinetics.
It is also used alone or with dabrafenib to treat certain types of melanoma.
Alternative agents should be considered during administration with dabrafenib when possible.
No clinically relevant effect of dabrafenib or its metabolites on the QTc interval was observed.
New primary melanomas have been reported in clinical trials in patients treated with dabrafenib.
Venous thromboembolism can occur when dabrafenib mesylate is used in combination with trametinib.
